Publications by authors named "Paola Neri"

81Publications

The impact of COVID-19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single-center experience.

Eur J Haematol 2020 Nov 16. Epub 2020 Nov 16.

Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada.

View Article and Find Full Text PDF
November 2020

Clonal hematopoiesis in myeloma: root of all maladies!

Authors:
Paola Neri

Blood 2020 Jun;135(26):2330-2331

University of Calgary.

View Article and Find Full Text PDF
June 2020

Deregulation of Adaptive T Cell Immunity in Multiple Myeloma: Insights Into Mechanisms and Therapeutic Opportunities.

Front Oncol 2020 5;10:636. Epub 2020 May 5.

Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.

View Article and Find Full Text PDF
May 2020

Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) for the Treatment of Newly Diagnosed AL Amyloidosis: Impact of Response on Survival Outcomes.

Clin Lymphoma Myeloma Leuk 2020 06 7;20(6):394-399. Epub 2019 Nov 7.

Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada. Electronic address:

View Article and Find Full Text PDF
June 2020

Anti-myeloma potential of ruxolitinib in co-existing JAK2V617F-positive smouldering myeloma and polycythaemia vera.

Br J Haematol 2020 05 20;189(3):e114-e118. Epub 2020 Feb 20.

Tom Baker Cancer Center, Department of Medical Oncology and Hematology, University of Calgary, Calgary, Alberta, Canada.

View Article and Find Full Text PDF
May 2020

The Pandora's box of thalidomide analogs and their substrates.

Authors:
Paola Neri

Blood 2019 07;134(2):105-106

University of Calgary.

View Article and Find Full Text PDF
July 2019

Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center.

Leuk Lymphoma 2019 12 13;60(13):3199-3203. Epub 2019 Jun 13.

Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada.

View Article and Find Full Text PDF
December 2019

From Inhibition to Degradation: Targeting the Antiapoptotic Protein Myeloid Cell Leukemia 1 (MCL1).

J Med Chem 2019 06 4;62(11):5522-5540. Epub 2019 Jun 4.

Arnie Charbonneau Cancer Institute , University of Calgary , 3280 Hospital Drive NW , T2N 4Z6 Calgary , Alberta , Canada.

View Article and Find Full Text PDF
June 2019

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.

Nat Commun 2019 04 23;10(1):1911. Epub 2019 Apr 23.

Department of Hematology and Medical Oncology, Emory University School of Medicine, 1365 Clifton Rd. NE, Atlanta, GA, 30322, USA.

View Article and Find Full Text PDF
April 2019

Functional profiling of venetoclax sensitivity can predict clinical response in multiple myeloma.

Leukemia 2019 05 24;33(5):1291-1296. Epub 2019 Jan 24.

Department of Hematology and Medical Oncology, Emory University School of Medicine and the Winship Cancer Institute of Emory University, Atlanta, GA, USA.

View Article and Find Full Text PDF
May 2019

Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance.

Mediterr J Hematol Infect Dis 2019 1;11(1):e2019007. Epub 2019 Jan 1.

Tom Baker Cancer Center, Department of Medical Oncology and Hematology, Calgary, AB, Canada.

View Article and Find Full Text PDF
January 2019

CRISPRing the CRL4 RING in multiple myeloma.

Authors:
Paola Neri

Blood 2018 09;132(12):1219-1220

University of Calgary.

View Article and Find Full Text PDF
September 2018

CD86 regulates myeloma cell survival.

Blood Adv 2017 Nov 16;1(25):2307-2319. Epub 2017 Nov 16.

Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.

View Article and Find Full Text PDF
November 2017